Squamous Cell Carcinoma (SCC) ICD-10: C44.9
Often searched as: skin sore that won't heal, scaly patch on face that bleeds, crusty spot on skin, non healing wound on skin, rough red patch on ear or face, skin cancer on sun damaged skin, wart like growth that grows fast, scab that keeps coming back…
Clinical urgency level
Systems Affected
Severity Levels
mild
Well-differentiated, small (<2cm), localized SCC on low-risk site — excellent prognosis with surgical excision, >95% cure rate.
moderate
Larger lesion (>2cm), high-risk location (ear, lip, temple), or poorly defined borders — requires wider excision, possible Mohs surgery, and sentinel node consideration.
severe
Deeply invasive SCC, perineural invasion, lymph node involvement, or distant metastases — requires multidisciplinary oncologic care including surgery, radiation, and possibly immunotherapy (cemiplimab).
Red Flags
- A scaly, crusted, or ulcerated spot that doesn't heal after 4–6 weeks
- A sore that bleeds easily with minor contact
- Rapid growth of a skin lesion over weeks to months
- A wart-like growth on the lip, ear, or face that is firm and enlarging
- Numbness, tingling, or pain in skin near a lesion (possible perineural invasion)
- A swollen lymph node near a known or suspicious skin lesion
Clinical Presentation
Squamous cell carcinoma — ulcerated, crusted lesion on the ear
Source: Wikimedia Commons (CC BY-SA 3.0 )
SCC image gallery — DermNet NZ
View gallery on DermNet NZ (image gallery reference)When to See a Doctor
See a dermatologist promptly for any non-healing skin sore, scaly or crusty patch, or growing bump — especially on sun-exposed areas like the face, ears, scalp, or hands. Early SCC is highly curable; delay significantly worsens prognosis. Immunosuppressed patients (transplant recipients, HIV) should have regular skin checks as SCC can be aggressive.
Differential Diagnosis
- Actinic keratosis (precancerous — SCC in situ predecessor)
- Basal cell carcinoma (pearlescent border, less likely to metastasize)
- Keratoacanthoma (rapidly growing but often self-resolving — histologically similar)
- Melanoma (pigmented lesions)
- Merkel cell carcinoma (rare, aggressive neuroendocrine)
- Chronic ulcer or wound
- Verruca vulgaris (wart — viral)
Comorbidities
- Actinic keratosis (direct precursor lesion)
- Organ transplant immunosuppression (100x increased SCC risk)
- HIV / AIDS
- Xeroderma pigmentosum
- Chronic skin inflammation (HS, burn scars — Marjolin's ulcer)
- Albinism
- Previous SCC or basal cell carcinoma
Prognosis
When caught early, SCC has a cure rate exceeding 95% with surgery. High-risk features — size >2cm, depth >4mm, perineural invasion, immunosuppression, or location on ear/lip — significantly worsen prognosis. Metastatic SCC occurs in 2–5% of cases but carries a 5-year survival of only ~30–50%. Immunotherapy (cemiplimab, pembrolizumab) has transformed treatment for advanced or metastatic SCC. Transplant recipients have the highest risk and require lifelong dermatologic surveillance.
Detailed Overview
Tags

Analyze your skin and hair with AI
Instantly analyze your skin with AI and get personal recommendations.
- - Get instant skin analysis
- - Personalized results from AI

* The scan result is not a diagnosis. To obtain a diagnosis and a treatment recommendation, consult your doctor.
Explore more conditions
Learn about other skin and hair conditions.